Podcasts about bcps

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Amber Lanae Martirosov, associate clinical professor of pharmacy practice at Wayne State University and clinical specialist at Henry Ford Hospital. She shares what inspired her to pursue a career in pharmacy and offers insights into the many paths within the profession, highlighting how pharmacists make a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

Every high-performing business has one thing in common: reliability. Hospitals cannot afford mistakes. Neither can you. In this episode of Beyond The Claim, Vince Perri sits with Anay Moscu, PharmD, BCPS, BCOP, ACRP-CP, Director of Pharmacy for Outpatient Infusion Centers at Moffitt Cancer Center, to uncover the systems that literally save lives and show how you can use them to scale your company faster. What you will learn: • The Stop Error Stack: how hospitals eliminate million-dollar mistakes • Why every business needs independent checks and hard stops • The Empathy with Accountability formula for leading under pressure • How to design checklists people actually follow • AI tools hospitals use today that you can apply to your business Chapters: 00:00 Intro: Checklists That Save Lives 01:52 What Oncology Pharmacy Really Does 05:40 How Clinical Trials and Infusion Workflows Operate 09:28 The Stop Error Stack: Eliminating Mistakes 13:35 Clean Rooms, Barcoding, and Validation 17:10 Building Systems That People Actually Follow 21:22 Hiring For Detail And Team Fit 26:45 Balancing Empathy With Accountability 32:12 Getting Buy-In Across Teams 37:44 AI And Automation In Modern Pharmacy 42:55 Translating Hospital Systems To Business Growth 48:05 Life Advice: Be Present And Give Yourself Grace 52:00 Outro And Free Checklist Guest Contact Links

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.

GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a higher risk of various ocular disorders, especially with long-term use. This episode reviews the findings of these studies, places them in context with the overall benefits of GLP-1s, and covers what pharmacists should know when counseling patients. Listen in to enhance your ability to guide safe, informed medication choices and stay updated on emerging safety information. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJamie Pitlick, PharmD, BCPS, BC-ADMProfessor and Chair of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Jamie Pitlick have no relevant financial relationships with ineligible companies to disclose.  Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the potential relationship between GLP-1 receptor agonist use and the development of ocular disorders.2. Identify key considerations for pharmacist counseling related to GLP-1 therapy and ocular health.0.05 CEU/0.5 HrUAN: 0107-0000-25-311-H01-PInitial release date: 10/27/2025Expiration date: 10/27/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Michael Wang, MD For patients with mantle cell lymphoma (MCL) who relapse after BTK inhibitor (BTKi) therapy, treatment decisions can be complex and time sensitive. That's why understanding how tumor biology and risk features can guide selection between immunomodulatory regimens and CAR T-cell therapy is essential. Tune in to hear Dr. Charles Turck speak with Dr. Michael Wang about practical, evidence-based strategies for managing relapsed/refractory MCL. Dr. Wang is a Professor in the Department of Lymphoma and Myeloma in the Department of Stem Cell Transplantation at MD Anderson Cancer Center in Houston, Texas.

Pharmacy driven medication history programs are essential for accurate transitions of care and patient safety, especially in rural and resource-limited settings. Jenny Slavens, from IU Health Arnett shares how her team built a 24/7 regional program that provides medication history support for their community hospital and several critical access facilities. She discusses the shift from a nurse-led to a pharmacy technician-driven model, the operational challenges of scaling services across multiple sites, and the decision to use phone-based interviews to streamline workflows.   Speaker:  Jenny Slavens, PharmD, BCPS  Pharmacy Manager Inpatient Clinical Pharmacy Services  Department of Pharmacy Indiana University Health - West Region   Host:  Jim Lichauer, PharmD, BCPS, FASHP Sr PI Program Director, Pharmacy Performance Improvement Programs Vizient   Show notes: [00:52] – Jenny outlines the structure of the medication history team at IU Health Arnett and how the program operates across facilities [02:10] – Discussion of coverage for critical access hospitals and how the team manages varying hours across sites [02:53] – The evolution from a nurse-led process to a pharmacy-driven model for medication history documentation [04:08] – Why the team shifted from using web-based technology to phone-based medication histories for efficiency and safety [05:20] – How bidirectional communication between pharmacy staff and physicians is maintained through the electronic medical record system [07:03] – Establishing the goal of completing 80% of medication histories within four hours of admission to support timely care decisions [08:55] – How the newly added Tipton facility improved from 10% to 72% completion of medication histories [10:56] – Strategies for balancing staff workload across inpatient, surgical, and emergency admissions [14:22] – Demonstrating the value of the medication history process and creatively using FTE staffing to improve coverage and efficiency   Links | Resources: Contacting Knowledge on the Go: picollaboratives@vizientinc.com   Subscribe Today! Apple Podcasts Spotify YouTube Android RSS Feed

PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated Version   

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Sammons, MD About 40 percent of patients with metastatic HR+/HER2- breast cancer have an activating mutation in the PIK3CA gene,1,2 which plays a key role not only in tumor growth, but also in driving resistance to endocrine therapy.3-5 And while there are several FDA-approved PI3K pathway-targeted agents for patients with PIK3CA tumor mutations,6-8 they come with challenges, like modest efficacy and on-pathway effects.9-12 Given this unmet need, the ReDiscover trial evaluated the investigational agent RLY-2608 in combination with fulvestrant in in patients with PIK3CA-mutated HR+/HER2- aBC previously treated with a CDK4/6 inhibitor.13 Joining Dr. Charles Turck to share updated safety and efficacy data from the trial is Dr. Sarah Sammons, a Senior Physician at the Dana-Farber Cancer Institute and an Assistant Professor of Medicine at Harvard Medical School in Boston. References: Vasan N, Cantley LC, Vasan N, Cantley LC. At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nat Rev Clin Oncol. 2022;19(7):471-485. doi:10.1038/s41571-022-00633-1 Network TCGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61-70. doi:10.1038/nature11412 Saal LH, Johansson P, Holm K, et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor …

With HortWeek senior reporter Rachael Forsyth fresh from the GrootGroenPlus trade show, we hear how European growers are tackling the challenge of imports/ exports with the UK - with producers saying they would be "delighted" to see the SPS agreement come into force.HortWeek editor Matthew Appleby and Rachael talk about:Inspection regimes and paperwork both sides of the border, and how it is affecting European tradersThe latest round of delays and reports of damaged plants at BCP SevingtonHow 'experiences' could transform the fortunes of garden centres and horticulture showsHow new analysis of horticulture company results is showing who is doing wellDo check out our huge archive of HortWeek Podcast interviews with an unrivalled selection of prominent and fascinating figures from all corners of the horticulture sector. Hosted on Acast. See acast.com/privacy for more information.

ASHP's education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Welcome to Pop & Politics, where celebrity scandals collide with political firestorms!

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Marilyn N. Bulloch, PharmD, BCPS, FCCM, welcomes Matheus Bannach, MD, of Urgency Hospital of Goyes in the Eruseo-Dorne Cancer Hospital in Brazil. They discuss Dr. Bannach's article, “Transfusion Practices in Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” published in the April 2025 issue of Critical Care Medicine. The study compared liberal and restrictive strategies for patients with traumatic brain injury (TBI). They found that a liberal transfusion strategy results in better neurologic outcomes than a restrictive strategy. Drs. Bulloch and Bannach discuss the importance of optimizing transfusion thresholds, the risks and benefits of blood transfusion for critically ill patients, and the limited supply of donated blood. The conversation also covers study methodology. Dr. Bannach explains the choice of main end point for the study, the process of selecting articles to include, and the rigorous peer review process. Listeners will find guidance for optimizing blood transfusion in patients with TBI, as well as key insights into review methodology. More discussion of this article can be found in the April 2025 Critical Content video. Resources referenced in this episode: Transfusion Practices in Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Larcipretti ALL, et al. Crit Care Med. 2025;53:e963-e972).

Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice.  You'll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice.  Special guests:Bharati Bhardwaja, PharmD, BCPS, LSSBBRheumatology Clinical Pharmacy SpecialistKaiser Permanente ColoradoMegan May, PharmD, BCOP, FHOPA, FAPOClinical Oncology Pharmacy SpecialistBaptist Health Lexington/Hamburg Cancer Care CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure, Dr. Megan May reports relevant financial relationships [lung cancer] with Amgen, AstraZeneca, Pharmacosmos (speakers bureau). The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in August 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Facts About BiosimilarsChart: Comparison of Insulins (United States)Chart: Biologics for Rheumatoid ArthritisChart: Biologics for Crohn's DiseaseUse code mt1025 at checkout for 10% off a new subscription.Send us a text****

En la Farmacia Minorista de Salinas Valley Health, entendemos que sus necesidades de salud son únicas, y estamos comprometidos a ofrecer atención experta adaptada a sus requerimientos específicos. Conozca más escuchando este podcast con la farmacéutica Jasmine Ho, PharmD, BCPS.

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Marilyn N. Bulloch, PharmD, BCPS, FCCM, welcomes Bram Tilburgs, RN, PhD, of Radboud University Medical Center in Nijmegen, Netherlands. They discuss Dr. Tilburgs' article, “Associations Between Physical, Cognitive, and Mental Health Domains of Post-Intensive Care Syndrome and Quality of Life: A Longitudinal Multicenter Cohort Study,” published in the January 2025 issue of Critical Care Medicine. The conversation offers key insights into the prevalence and long-term effects of post-intensive care syndrome (PICS). Dr. Tilburgs' study surveyed intensive care unit (ICU) patients on their quality of life three months, twelve months, and two years after ICU discharge. The survey included physical, cognitive, and mental health domains. The findings show a significant link between PICS and diminished long-term quality of life. Drs. Bulloch and Tilburgs discuss how these results highlight the need for PICS prevention across all three domains. They review potential strategies, such as diaries to help patients better understand their ICU experience. Dr. Tilburgs also highlights the benefits of his institution's discussion group for ICU survivors. Listeners will gain key insights on the long-term effects of PICS, actionable ideas for improving ICU patient care, and ideas for future research. Resources referenced in this episode:  Associations Between Physical, Cognitive, and Mental Health Domains of Post-Intensive Care Syndrome and Quality of Life: A Longitudinal Multicenter Cohort Study (Tilburgs B, et al. Crit Care Med. 2025 Jan;53:e74-e86).

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jonathon B. Cohen, MD, MS As the therapeutic landscape for follicular lymphoma continues to evolve, CAR T-cell therapy is emerging as a transformative option for select patients with relapsed or high-risk disease. But it also comes with a lot of important considerations, like knowing when to refer and how to manage common adverse events. Joining Dr. Charles Turck to explore how CAR T fits into the broader treatment algorithm for follicular lymphoma is Dr. Jonathan Cohen. Not only is he a Professor in the Department of Hematology and Medical Oncology at the Emory University School of Medicine, but he's also the Co-Director of the Lymphoma Program at the Winship Cancer Institute of Emory University in Atlanta.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jonathon B. Cohen, MD, MS As the therapeutic landscape for follicular lymphoma continues to evolve, CAR T-cell therapy is emerging as a transformative option for select patients with relapsed or high-risk disease. But it also comes with a lot of important considerations, like knowing when to refer and how to manage common adverse events. Joining Dr. Charles Turck to explore how CAR T fits into the broader treatment algorithm for follicular lymphoma is Dr. Jonathan Cohen. Not only is he a Professor in the Department of Hematology and Medical Oncology at the Emory University School of Medicine, but he's also the Co-Director of the Lymphoma Program at the Winship Cancer Institute of Emory University in Atlanta.

On this milestone episode of Unscripted, the AMCP Podcast, they celebrate the 30th anniversary of the Journal of Managed Care & Specialty Pharmacy (JMCP). Host Susan Cantrell, AMCP CEO, is joined by Laura Happe, PharmD, MPH, Editor-in-Chief of JMCP, and Pat Gleason, PharmD, BCPS, FCCP, FAMCP, Assistant Vice President, Health Outcomes at Prime Therapeutics to reflect on the journal's evolution from its 1995 launch to today's leading voice in managed care pharmacy. Highlights include JMCP's role in shaping policy, advancing research, and tackling pressing issues such as drug pricing, equity, and access—while looking ahead to the future of pharmacy innovation and collaboration. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

ASHP's senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP's senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTErica Marchese, PharmD, BCPS, BCOP, BCSCP, MHAClinical Pharmacy Program DirectorCity of HopeJoshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care.2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.0.05 CEU/0.5 HrUAN: 0107-0000-25-292-H01-PInitial release date: 9/15/2025Expiration date: 9/15/2026Additional CPE details can be found here.

As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTErica Marchese, PharmD, BCPS, BCOP, BCSCP, MHAClinical Pharmacy Program DirectorCity of HopeJoshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care.2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.0.05 CEU/0.5 HrUAN: 0107-0000-25-292-H01-PInitial release date: 9/15/2025Expiration date: 9/15/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Samuel Yamshon, MD The treatment landscape for large B-cell lymphoma (LBCL) is rapidly evolving due to the growing integration of bispecific antibodies into second-line care. While these agents offer promising, targeted options—not only for patients ineligible for CAR T-cell therapy, but also as complementary strategies in combination with chemoimmunotherapy—they raise important questions around sequencing, durability, and patient selection. Joining Dr. Charles Turck to explore the real-world implications of this evolving approach is Dr. Samuel Yamshon, Director of the Cellular Therapy Service and an Assistant Professor of Medicine at Weill Cornell Medicine in New York.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sairah Ahmed, MD CAR T-cell therapies have helped transform the treatment of aggressive lymphomas, but could they also change the game for slower-growing, harder-to-treat diseases like marginal zone lymphoma? Based on new data from the TRANSCEND FL study, liso-cel achieved a 95 percent overall response rate and sustained 24-month progression-free survival in relapsed/refractory marginal zone lymphoma. Here with Dr. Charles Turck to share the key efficacy and safety findings is Dr. Sairah Ahmed, Professor in the Department of Lymphoma and Myeloma and CAR T Program Director at MD Anderson Cancer Center.

The Battle Creek Public Schools Education Foundation is readying for another Bearcat Tailgate event, which has raised more than $86,000 for educational support.BCPSEF President Carrie Briggs - who also serves as the district's Bearcat Advantage Program coordinator - discusses how the event helps, as well as the free fun, food and resources for attendees.Episode ResourcesBCPS Education FoundationBCPS Bearcat AdvantageABOUT COMMUNITY MATTERSFormer WBCK Morning Show host Richard Piet (2014-2017) returns to host Community Matters, an interview program focused on community leaders and newsmakers in and around Battle Creek. Community Matters is heard Saturdays at 8:00 AM on WBCK-FM (95.3) and anytime at battlecreekpodcast.com.Community Matters is sponsored by Lakeview Ford Lincoln and produced by Livemic Communications.

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Evandro Bezerra, MD As CAR T-cell therapy advances, so does the complexity of adverse event monitoring. Due to evolving insights into acute toxicities, infections, cytopenias, and secondary malignancies, both inpatient and outpatient care models are adapting to meet new standards. Joining Dr. Charles Turck to discuss practical strategies and emerging tools for managing post-CAR T toxicities across the continuum of care is Dr. Evandro Bezerra, Clinical Assistant Professor at Ohio State University Comprehensive Cancer Center in Columbus.

On episode 525 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews author and lactation pharmacologist Dr. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS. In the course of their conversation, Keith and Dr. Krutsch discuss the history and science behind the very specialized topic of lactation pharmacology, and why it should be of great importance to all healthcare professionals. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS is a lactation pharmacologist who literally wrote the book on medications in human milk with Dr. Thomas Hale, Hale's Medications and Mothers' Milk. Dr. Krutsch is both Director of the Infant Risk Center and Associate Professor at the Texas Tech University Health Sciences Center, and advises the Food and Drug Administration, the Human Milk Banking Association of Northern America, and the pharmaceutical industry on lactation pharmacology and lactation research. Dr. Krutsch believes families deserve better answers to questions about breastfeeding and medications, and designs research that addresses their questions while creating a comprehensive information cycle that empowers families. This episode of the Nurse Keith Show is brought to you in collaboration with Springer Publishing, who have been delivering award-winning healthcare education and exam prep materials focused on nursing, behavioral health, and the health sciences for more than 70 years. We thank Springer Publishing for their support. Connect with Dr. Kaytlin Krutsch and The Infant Risk Center ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn Instagram Facebook Infant Risk Center website Hale's Medications and Mother's Milk Contact Nurse Keith about holistic career coaching to elevate your nursing and healthcare career at ⁠⁠⁠⁠⁠⁠⁠NurseKeith.com⁠⁠⁠⁠⁠⁠⁠. Keith also offers services as a motivational and keynote speaker and freelance nurse writer. You can always find Keith on⁠⁠⁠⁠⁠⁠⁠ LinkedIn⁠⁠⁠⁠⁠⁠⁠. Are you looking for a novel way to empower your career and move forward in life? Keith's wife, Shada McKenzie, is a gifted astrologer and reader of the tarot who combines ancient and modern techniques to provide valuable insights into your motivations, aspirations, and life trajectory, and she offers listeners of The Nurse Keith Show a 10% discount on their first consultation. Contact Shada at ⁠⁠⁠⁠⁠⁠⁠TheCircelandtheDot.com ⁠⁠⁠⁠⁠⁠⁠or shada@thecircleandthedot.com.

The Future Is Now: APhA President Randy McDonough on Leading Change in Independent PharmacyWhat does the future of independent pharmacy look like—and how do we get there?In this powerful episode of Independent Insights, APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Randy shares his frontline perspective as both a national leader and a practicing owner.Whether you're a pharmacist, technician, or pharmacy owner, this episode will leave you inspired, informed, and ready to take action. Tune in and be part of the movement to redefine the role—and the value—of independent pharmacy in healthcare.HostSuzanne Feeney, PharmDSenior Director, Pharmacy SolutionsMcKesson/ Health MartGuestsRandy McDonough, PharmD, MS, BCGP, BCPS, FAPhAPresident, American Pharmacists Association (APhA) and Health Mart Pharmacy OwnerNancy Lyons, BSPharm, MBA, CDCESVice President, Chief Pharmacy OfficerMcKesson/ Health MartResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses, advanced trainings, and more Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

IVPN Critical Care Listserv

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Forat Lutfi, MD Guest: Nilanjan Ghosh, MD, PhD For patients with relapsed/refractory large B-cell lymphoma, timely access to CAR T-cell therapy can be life-saving, but communication gaps between referring physicians and CAR T centers can lead to delays or missed opportunities. Fortunately, practical strategies like building strong referral networks, improving direct communication, and aligning on shared care responsibilities can streamline access and improve outcomes. Joining Dr. Charles Turck to share their insights on how we can bridge these communication gaps are Drs. Forat Lutfi and Nilanjan Ghosh. Dr. Lutfi is an Assistant Professor of Hematologic Malignancies and Cellular Therapeutics at University of Kansas Medical Center, and Dr. Ghosh is a Professor of Cancer Medicine at the Wake Forest University School of Medicine in Charlotte, North Carolina.

In this IVPN Critical Care x IVPN Voice collaboration, we dive into the concept of Fluid Stewardship: Fluids are Drugs.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jacqueline Wong, MD, MSCR, FACOG For patients with endometriosis, treatment delays can profoundly impact both quality of life and clinical outcomes. Proactive strategies that address logistical barriers—such as prior authorizations—combined with education and multidisciplinary support are essential in improving care. Join Dr. Charles Turck and Dr. Jacqueline Wong as they explore practical approaches for managing this complex condition and navigating potential hurdles. Dr. Wong is a minimally invasive gynecologic surgeon and an Assistant Professor of Obstetrics and Gynecology in the School of Medicine at Oregon Health and Science University in Portland.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sairah Ahmed, MD The treatment landscape for relapsed/refractory (R/R) large B-cell lymphoma has significantly shifted, with CAR T-cell therapies now offering curative potential in the second-line setting. But these advances also raise important questions, like how to identify the right candidates and navigate logistical barriers to ensure timely, equitable access. Joining Dr. Charles Turck to explore these critical considerations is Dr. Saira Ahmed, Associate Professor in the Department of Lymphoma and Myeloma and the CAR T Program Director in the Department of Lymphoma and Myeloma at the MD Anderson Cancer Center.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sairah Ahmed, MD The treatment landscape for relapsed/refractory (R/R) large B-cell lymphoma has significantly shifted, with CAR T-cell therapies now offering curative potential in the second-line setting. But these advances also raise important questions, like how to identify the right candidates and navigate logistical barriers to ensure timely, equitable access. Joining Dr. Charles Turck to explore these critical considerations is Dr. Saira Ahmed, Associate Professor in the Department of Lymphoma and Myeloma and the CAR T Program Director in the Department of Lymphoma and Myeloma at the MD Anderson Cancer Center.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Neil M. Iyengar, MD Guest: Komal Jhaveri, MD, FACP The second-line treatment of HR+/HER2-advanced breast cancer has evolved in recent years, particularly with the rise of biomarker-driven strategies targeting PI3Kα and other mutations. But given these advances, there's a lot we need to think about when selecting therapy, like the differences between selective and non-selective inhibitors, toxicity profiles, and shared decision-making. Joining Dr. Charles Turck to share their insights on those key considerations and how we can personalize care for patients with PI3Kα-mutated HR+/HER2- advanced breast cancer are Drs. Komal Jhaveri and Neil Iyengar. Dr. Jhaveri is the section head for the Endocrine Therapy Research Program in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center, and Dr. Iyengar is the Co-Director of the Breast Oncology Program at the Winship Cancer Institute at Emory University.

Listen in as we explore the latest pharmacologic strategies for HIV prevention—before and after exposure. Our expert panel breaks down key considerations for PrEP and PEP, including indications, drug selection, dosing, and monitoring.Special guest(s):Caitlin Prather, PharmD, BCACP, AAHIVPClinical Pharmacy Specialist, Ambulatory CareInova Health SystemMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical PharmacistChildren's Hospital ColoradoYou'll also hear practical advice from TRC's Editorial Advisory Board member:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine - PhoenixFor the purposes of disclosure, Dr. Prather reports a relevant financial relationship [HIV PrEP] with Viiv Healthcare (speakers bureau).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in June 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Checklist: HIV Pre-Exposure Prophylaxis (PrEP)Checklist: HIV Postexposure Prophylaxis (PEP) ChecklistSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.

In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Marilyn N. Bulloch, PharmD, BCPS, FCCM, speaks with Christy C. Forehand, PharmD, BCCCP, FCCM, about retaining highly skilled pharmacists in the ICU setting. Dr. Forehand, a clinical pharmacy specialist and residency program director at Augusta University Medical Center and the University of Georgia College of Pharmacy, shares evidence-based insights and personal reflections on how pharmacist retention directly impacts quality and safety in patient care. The conversation highlights growing concerns around burnout and attrition among ICU pharmacists, underscoring how their involvement improves clinical and economic outcomes—ranging from medication safety and reduced ventilator days to optimized transitions of care. Drawing on American College of Clinical Pharmacy (ACCP) publications and American Society of Health-System Pharmacists (ASHP) guidance, Dr. Forehand outlines strategies for building retention plans that prioritize recognition, advancement opportunities, career mentorship, and structural supports such as protected administrative time. She emphasizes how institutional practices such as improved scheduling, remote work models, and role-specific stipends can prevent burnout while reinforcing team trust and efficiency. Resources referenced in this episode: SCCM's Leadership, Empowerment, and Development (LEAD) Program, which supports professional development Rewards, Recognition, and Advancement for Clinical Pharmacists (Bondi DS, et al. J Am Coll Clin Pharm. 2023;6:427-439)

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Whitney Trotter Ross, MD, MSCI Despite advances in endometriosis treatment, bias and stigma continue to delay diagnosis and disrupt care for many patients. Informed, empathetic care is key for supporting diverse patient populations. Dr. Charles Turck sits down with Dr. Whitney Ross to unpack how historical misconceptions still influence prescribing habits and discuss actionable strategies for counseling, selecting a treatment plan, and building trust. Dr. Ross is an Assistant Professor of Obstetrics and Gynecology in the Division of Minimally Invasive Gynecologic Surgery at Washington University in St. Louis.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Whitney Trotter Ross, MD, MSCI Despite advances in endometriosis treatment, bias and stigma continue to delay diagnosis and disrupt care for many patients. Informed, empathetic care is key for supporting diverse patient populations. Dr. Charles Turck sits down with Dr. Whitney Ross to unpack how historical misconceptions still influence prescribing habits and discuss actionable strategies for counseling, selecting a treatment plan, and building trust. Dr. Ross is an Assistant Professor of Obstetrics and Gynecology in the Division of Minimally Invasive Gynecologic Surgery at Washington University in St. Louis.

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Mariah Hollabaugh, director of pharmacy at Citizens Memorial Hospital, Hayle Gillespie, medication access specialist at Citizens Memorial Hospital, and Jodie Gregg, an advocate and patient. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Drug shortages continue to be a significant issue in the healthcare system, affecting various aspects of patient care and imposing substantial costs on hospitals and health systems. According to Vizient's 2024 drug shortages survey, U.S. hospitals are spending approximately 20 million hours annually managing these shortages, resulting in nearly $900 million in associated labor costs. The survey highlights that 74% of facilities reported exceeding their pharmacy budgets due to drug shortages, with pediatric facilities facing particularly significant financial and labor strain.   Kyle Hoelting, director of pharmacy supply assurance and stewardship and Nikola Markoski, director of pharmacy sourcing strategic solutions and analytics join host Katie Korte, vice president Vizient Reserve to delve into the results of Vizient's 2024 drug shortage survey.   Guest speakers:  Kyle Hoelting, Pharm.D, BCPS Director, Pharmacy Supply Assurance & Stewardship Vizient Center for Pharmacy Practice Excellence   Nikola Markoski, Pharm.D, MBA Director, Pharmacy Sourcing Strategic Solutions & Analytics Vizient   Host:  Katie Kortie, Pharm.D, MHA, BCPS, BCCCP Vice President, Strategy & Program Lead, Vizient Reserve Vizient   Show Notes: [00:47-01:14] Kyle and Niko Backgrounds [01:15-05:04] What's different about this year's survey and what made 2023 a critical year in the drug shortage landscape [05:05-08:27] How data was collected, what did the mix of information tells us and the biggest insights or patterns that surfaced in the survey [08:28-12:25] What Vizient's built or enabled that's made a difference in this space [12:26-15:55] How best to prepare for and respond to shortages from an inventory perspective   Links | Resources:  Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions Drug shortage stewardship: A novel solution for an old problem Vizient Key performance indicators for the management of drug shortages Vizient Essential Medications List   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong? Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD Music by Good Talk

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

We all know that clinician burnout negatively impacts the quality of patient care. That's why pharmacy residency accrediting bodies now emphasize resident well-being and professional sustainability as core components of residency training earlier in clinician careers. The American Society of Health-System Pharmacists (ASHP) Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies include a formal requirement for programs to address resilience, well-being, and burnout prevention, reflecting the increasing recognition of burnout in healthcare. Joining us to talk that out are Tony Huke, Senior Pharmacy Executive Director with Vizient Pharmacy Advisory Solutions and Kendra Gage, Inpatient Clinical Pharmacist and the PGY 1 Residency Program Director at UCHealth, University of Colorado Hospital in Aurora, Colorado.   Guest speakers:  Tony Huke, PharmD, BCPS, FASHP Senior Pharmacy Executive Director Vizient Pharmacy Advisory Solutions   Kendra Gage, PharmD, BCPS Inpatient Clinical Pharmacist PGY1 Pharmacy Residency Program Director UCHealth   Host:  Kerry Schwarz, PharmD, MPH  Senior Clinical Manager, Evidence-Based Medicine and Outcomes Center for Pharmacy Practice Excellence (CPPE)   Show Notes:  [01:11-03:25] What's new at the national level in terms of pharmacy resident resiliency and well-being [03:26-03:56] The intentionality of well-being in pharmacy residency programs [03:57-05:12] Examples from Kendra's program [05:13-06:40]  Program expectations to address resilience [06:41-08:33]  Assessment and potential metrics of resiliency programs [08:34-11:06]  The role of pharmacy leadership and residency program directors in resiliency [11:07-12:34] Impact of resiliency programs so far   Links | Resources: Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed